Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases.

Signal Transduct Target Ther · 2026 · PMC13233851 · PMID 42236671

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Importantly, the HM-NPs@LP group exhibited a downward trend in tumor volume from approximately day 24 compared to the peptide-free HM-NPs group, although the difference did not reach statistical significance at the study endpoint (Fig. 4c–f ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.